FDA Inspection 1198343 — Cipla Limited

Cipla Limited — FEI 3008581988

The FDA completed an inspection of Cipla Limited on Feb 17, 2023 in Pithampur, District Dhar. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Feb 17, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Pithampur, District Dhar (India)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.